Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,5213,540 of 20,252 grants

Active NON-SBIR/STTR RPGS
Implementing and Evaluating the Cancer Tracking System (CATSystem): A systems level intervention to improve Cervical Cancer screening, treatment referral and follow up in Kenya
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2023 – 2028

Abstract In Kenya, cervical cancer (CC) contributes to over 80% of female reproductive-tract cancers,4 yet only 16.4% of eligible women are screened for CC.5 This is far below the...

$5.28M
USD
Active NON-SBIR/STTR RPGS
Reflectance confocal microscopy-optical coherence tomography (RCM-OCT) imaging of oral lesions: Toward an affordable device and approach for developing countries
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2028

High rates of incidence and prevalence of oral cancers occur in 15-20 developing low-and-middle income countries (LMICs) in Asia and Africa. Visual clinical examination followed by...

$7.29M
USD
Completed TRAINING, INDIVIDUAL
Targeting fibrosis to change cancer outcomes
NATIONAL CANCER INSTITUTE Cincinnati Childrens Hosp Med Ctr United States 2023 – 2023

PROJECT SUMMARY Scleroderma (SSc) patients have more than a 300% increased risk of lung cancer, or Cancerous Scleroderma (CSc). SSc is a chronic autoimmune connective tissue diseas...

$10
USD
Active TRAINING, INDIVIDUAL
Metabolic vulnerabilities in cancers with impaired TCA cycle activity
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2027

PROJECT SUMMARY Cancer cells exploit multiple metabolic strategies to generate biosynthetic precursors that fuel malignant proliferation. Such metabolic redundancy and plasticity h...

$526.9K
USD
Active NON-SBIR/STTR RPGS
Research Specialist in Cancer Genomics to Integrate Basic Research and Clinical Data
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

ABSTRACT Human cancers are complex diseases with pathobiology driven by heritable genetics, environmental exposures, somatic genomic and epigenomic alterations, and contributions f...

$1.13M
USD
Active NON-SBIR/STTR RPGS
Implementing and Evaluating the Cancer Tracking System (CATSystem): A systems level intervention to improve Cervical Cancer screening, treatment referral and follow up in Kenya
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2023 – 2028

Abstract In Kenya, cervical cancer (CC) contributes to over 80% of female reproductive-tract cancers,4 yet only 16.4% of eligible women are screened for CC.5 This is far below the...

$5.84M
USD
Completed NON-SBIR/STTR RPGS
Role of LSD1 in Triple Negative Breast Cancer Development and Therapeutic Response
NATIONAL CANCER INSTITUTE University of Iowa United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT Breast cancer (BC) is the most common cancer and the second leading cause of cancer death in American women. About 10-20% of breast cancers are triple-nega...

$3.49M
USD
Completed SBIR/STTR CONTRACTS
AUTOMATED DEIDENTIFICATION OF PATHOLOGY AND RADIOLOGY DATA
NATIONAL CANCER INSTITUTE Impact Business Information Solutions In... United States 2023 – 2025

The overall project objective is to optimize and automate the detection and redaction of PHI in radiology data (DICOM) and pathology data (Whole Slide Imaging - WSI) – both header...

$19.98M
USD
Completed SBIR/STTR CONTRACTS
NCI SBIR Contract Topic 428 Phase II (Solicitation Number: BAA 75N91022R00027): Cloud-based Liquid-biopsy and Radiomics Platform for the Cancer Research Data Commons
NATIONAL CANCER INSTITUTE Earlydiagnostics, Inc United States 2023 – 2025

Integrative analysis of multi-omics datasets is revolutionizing cancer research and patient care.To take advantage of the full breadth of CRDC’s petabyte-scale data, EarlyDx will s...

$19.95M
USD
Completed SBIR/STTR CONTRACTS
TOPIC 454 - SOFTWARE TO EVALUATE ARTIFICIAL INTELLIGENCE/MACHINE LEARNING MEDICAL DEVICES IN ONCOLOGY SETTINGS
NATIONAL CANCER INSTITUTE Gradient Health Inc United States 2023 – 2024

Supervised, Machine Learning based oncologic AI algorithms degrade over time and don’t generalize well. The FDA requires the conduct of standalone testing of radiologic, AI product...

$3.78M
USD
Completed SBIR/STTR CONTRACTS
Multi-Modality Imaging-Based Quantitative Pre/During/Post-Treatment Lymph Node Monitoring in Cancers
NATIONAL CANCER INSTITUTE Carina Medical, Llc United States 2023 – 2024

The correct determination of nodal metastatic disease is imperative for patient management in oncology, since the patient’s prognosis and subsequent treatment are inherently linked...

$4M
USD
Completed NON SBIR/STTR CONTRACTS
SERVICES TO EXTEND METHODS FOR RISK PREDICTION WITH A CONTINUOUS TIME MODEL FOR SURVIVAL UNDER COMPETING RISKS
NATIONAL CANCER INSTITUTE Unknown United States 2023 – 2024

THIS PURCHASE ORDER INCLUDES SERVICES TO EXTEND METHODS FOR RISK PREDICTION WITH A CONTINUOUS TIME MODEL FOR SURVIVAL UNDER COMPETING RISKS USING TWO-TIME SCALES

$247K
USD
Completed NON-SBIR/STTR RPGS
Role of LSD1 in Triple Negative Breast Cancer Development and Therapeutic Response
NATIONAL CANCER INSTITUTE University of Iowa United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT Breast cancer (BC) is the most common cancer and the second leading cause of cancer death in American women. About 10-20% of breast cancers are triple-nega...

$3.32M
USD
Active OTHER RESEARCH-RELATED
Development of abuse liability-based tobacco tax proposals: Experimental impact on tobacco-related socioeconomic cancer health disparities
NATIONAL CANCER INSTITUTE Virginia Polytechnic Inst and St Univ United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Nearly 30% of all cancer deaths are attributable to tobacco use. Tobacco taxes have positively impacted the prevalence of tobacco use and subsequently the...

$2.12M
USD
Active NON-SBIR/STTR RPGS
A novel AR degrader in castrate-resistant prostate cancer
NATIONAL CANCER INSTITUTE Wayne State University United States 2023 – 2028

Androgen receptor (AR) plays a critical role in prostate cancer (PCa) in all stages. While a majority of patients with PCa initially respond to androgen deprivation and/or anti-and...

$5.72M
USD
Active NON-SBIR/STTR RPGS
Engineered Nanoformulation for Immune-modulation in Cancer
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2023 – 2028

Expression of immune check point (ICP) molecules on tumor cells and the host immune cells, especially T-cells present in the tumor milieu, negatively impact the cancer treatment ou...

$5.35M
USD
Active TRAINING, INDIVIDUAL
Metabolic vulnerabilities in cancers with impaired TCA cycle activity
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2027

PROJECT SUMMARY Cancer cells exploit multiple metabolic strategies to generate biosynthetic precursors that fuel malignant proliferation. Such metabolic redundancy and plasticity h...

$539.9K
USD
Completed SBIR/STTR CONTRACTS
Multi-Modality Imaging-Based Quantitative Pre/During/Post-Treatment Lymph Node Monitoring in Cancers
NATIONAL CANCER INSTITUTE Carina Medical, Llc United States 2023 – 2024

The correct determination of nodal metastatic disease is imperative for patient management in oncology, since the patient’s prognosis and subsequent treatment are inherently linked...

$550K
USD
Completed NON-SBIR/STTR RPGS
Role of LSD1 in Triple Negative Breast Cancer Development and Therapeutic Response
NATIONAL CANCER INSTITUTE University of Iowa United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT About 10-20% of breast cancers are triple-negative breast cancers (TNBC), which have a poorer prognosis and worse clinical outcome than other types of BC....

$407.4K
USD
Active TRAINING, INDIVIDUAL
Targeting fibrosis to change cancer outcomes
NATIONAL CANCER INSTITUTE University of Cincinnati United States 2023 – 2028

PROJECT SUMMARY Scleroderma (SSc) patients have more than a 300% increased risk of lung cancer, or Cancerous Scleroderma (CSc). SSc is a chronic autoimmune connective tissue diseas...

$489.6K
USD